Breast HER2 Insitu Hybridization (HER2 ISH): Acceptable and unacceptable staining criteria impacting on interpretation

被引：0
|
作者：
Parry, S. [1 ]
Miller, K. [1 ]
Ibrahim, M. [1 ]
机构：
[1] UK NEQAS ICC & ISH, London, England
来源：
VIRCHOWS ARCHIV | 2012年 / 461卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：S258 / S258
页数：1
相关论文
共 50 条
  • [11] ISH-based HER2 diagnostics
    Rueschoff, Josef
    Nagelmeier, Iris
    Jasani, Bharat
    Stoss, Oliver
    PATHOLOGE, 2020, 41 (06): : 606 - 613
  • [12] Establishment of New Criteria for Automated HER2 RNA ISH Assessment
    Yanagita, Emmy
    Serrette, Rene
    Tsukamoto, Tetsuya
    Ohnishi, Chie
    Ohnishi, Takashi
    Ntiamoah, Peter
    Ross, Dara
    Yagi, Yukako
    LABORATORY INVESTIGATION, 2025, 105 (03)
  • [13] HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer
    Hou, Yanjun
    Nitta, Hiroaki
    Li, Zaibo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 147 (01) : 89 - 95
  • [14] Evaluation of analytical accuracy of HER2 status in patients with breast cancer Comparison of HER2 GPA with HER2 IHC and HER2 FISH
    Jensen, Steffen Grann
    Thomas, Peter Engel
    Christensen, Ib Jarle
    Balslev, Eva
    Hansen, Alastair
    Hogdall, Estrid
    APMIS, 2020, 128 (11) : 573 - 582
  • [15] ISH-based HER2 diagnostics
    Rueschoff, Josef
    Nagelmeier, Iris
    Jasani, Bharat
    Stoss, Oliver
    PATHOLOGE, 2021, 42 (SUPPL 1): : 62 - 68
  • [16] Updated HER2 In Situ Hybridization (ISH) Guidelines in Breast Cancer: Some Equivocal Findings
    Kos, Zuzana
    Craddock, Kenneth
    Berman, Hal
    Done, Susan
    Miller, Naomi
    Youngson, Bruce
    Mulligan, Anna Marie
    LABORATORY INVESTIGATION, 2015, 95 : 51A - 52A
  • [17] Updated HER2 In Situ Hybridization (ISH) Guidelines in Breast Cancer: Some Equivocal Findings
    Kos, Zuzana
    Craddock, Kenneth
    Berman, Hal
    Done, Susan
    Miller, Naomi
    Youngson, Bruce
    Mulligan, Anna Marie
    MODERN PATHOLOGY, 2015, 28 : 51A - 52A
  • [18] The frequency of HER2 amplification and the percentage of membrane staining in HER2 2+invasive carcinomas of the breast Reply
    Polonia, Antonio
    Canelas, Carolina
    Caramelo, Ana
    VIRCHOWS ARCHIV, 2022, 481 (02) : 329 - 330
  • [19] HER2 staining intensity has prognostic impact on patients with HER2 type invasive breast cancer
    Yi-Hsuan, H.
    Yen-Shu, L.
    Chih-Yi, H.
    Ling-Ming, T.
    ANNALS OF ONCOLOGY, 2018, 29
  • [20] Dual Contribution of Quantitative Image Analysis for the Evaluation of HER2 IHC Staining Quality, and Interpretation of HER2 Overexpression and HER2-Low Status in Breast Carcinoma
    Cossutta, Melissande
    Truumees, Birgit
    Papine, Alexandre
    Kristoffersen, Heidi
    Tatarinova, Ekaterina
    Homsy, Charles
    Nielsen, Soren
    Soussaline, Francoise
    LABORATORY INVESTIGATION, 2024, 104 (03) : S139 - S140
12345